PHARMAGREEN BIOTECH INC. EBITDA
PHARMAGREEN BIOTECH INC. EBITDA
- 2023-03-31: Basis Reported; EBITDA (m); Operating income -$187.98K; Depreciation and amortization (m).
- 2022-12-31: Basis Reported; EBITDA (m); Operating income -$181.09K; Depreciation and amortization (m).
- 2022-06-30: Basis Reported; EBITDA (m); Operating income -$241.22K; Depreciation and amortization (m).
- 2022-03-31: Basis Reported; EBITDA (m); Operating income -$1.04M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2023-03-31 | Reported | (m) | -$187.98K | (m) | (m) | (m) | (m) | (m) | $985.00 | (m) | (m) | (m) |
|---|
| 2022-12-31 | Reported | (m) | -$181.09K | (m) | (m) | (m) | (m) | -$19.50K | (m) | (m) | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$241.22K | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$1.04M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
|---|
| 2021-12-31 | Reported | (m) | -$203.66K | (m) | (m) | (m) | (m) | -$148.53K | (m) | (m) | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$232.38K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$136.95K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-12-31 | Reported | (m) | -$101.62K | (m) | (m) | (m) | (m) | -$4.38K | (m) | (m) | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$86.91K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$150.60K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-12-31 | Reported | (m) | -$117.12K | (m) | (m) | (m) | (m) | -$71.92K | (m) | (m) | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$58.31K | (m) | (m) | (m) | (m) | (m) | (m) | -$32.66K | (m) | -$802.00 |
|---|
| 2019-03-31 | Reported | (m) | -$93.57K | (m) | (m) | (m) | (m) | (m) | (m) | $6.89K | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$205.34K | (m) | (m) | (m) | $11.08K | -$270.55K | (m) | $29.72K | (m) | (m) |
|---|
| 2018-06-30 | Reported | (m) | -$328.45K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2022-09-30 | Reported | (m) | -$1.10M | (m) | (m) | (m) | (m) | -$426.57K | (m) | (m) | (m) | $0.00 |
|---|
| 2021-09-30 | Reported | (m) | -$744.06K | (m) | (m) | (m) | (m) | -$206.08K | (m) | (m) | (m) | $0.00 |
|---|
| 2020-09-30 | Reported | (m) | -$485.76K | (m) | (m) | (m) | (m) | -$607.63K | (m) | (m) | (m) | $0.00 |
|---|
| 2019-09-30 | Reported | (m) | -$642.18K | (m) | (m) | (m) | $196.13K | -$317.83K | (m) | $3.96K | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$748.72K | (m) | (m) | (m) | $251.31K | -$785.53K | (m) | $7.62K | (m) | (m) |
|---|